Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

The study showed that Glucagon-like peptide-1 (GLP-1) analogues — drugs developed to treat obesity — likely curb alcohol ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

Medications such as liraglutide or semaglutide taken for weight loss also have the potential to reduce alcohol consumption b ...

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which are sometimes taken off-label for weight loss. Some pharmacies also ...

As new figures show how obesity is rising among children and teenagers, doctors debate if weight loss jabs are the answer ...

Adverse reactions to weight-loss jabs are set to soar by more than 350% in a single year, according to the latest data.

Ozempic is primarily a diabetes drug, whereas Wegovy is a weight loss drug with a higher dose of semaglutide than Ozempic. Confusing? You betcha. Here’s a quick summary to help. It’s FDA ...

Doctors have warned of some hidden and potentially fatal side effects of using Ozempic amid the increasing popularity of the ...

The global race for weight loss solutions has firmly arrived in India—bringing with it hope, hype, and a host of unanswered ...